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Abstract
Background: The use of information and communication technologies to manage chronic diseases allows the
application of integrated care pathways, and the optimization and standardization of care processes. Decision
support tools can assist in the adherence to best-practice medicine in critical decision points during the execution
of a care pathway.
Objectives: The objectives are to design, develop, and assess a clinical decision support system (CDSS) offering a
suite of services for the early detection and assessment of chronic obstructive pulmonary disease (COPD), which
can be easily integrated into a healthcare providers’ work-flow.
Methods: The software architecture model for the CDSS, interoperable clinical-knowledge representation, and
inference engine were designed and implemented to form a base CDSS framework. The CDSS functionalities were
iteratively developed through requirement-adjustment/development/validation cycles using enterprise-grade
software-engineering methodologies and technologies. Within each cycle, clinical-knowledge acquisition was
performed by a health-informatics engineer and a clinical-expert team.
Results: A suite of decision-support web services for (i) COPD early detection and diagnosis, (ii) spirometry quality-
control support, (iii) patient stratification, was deployed in a secured environment on-line. The CDSS diagnostic
performance was assessed using a validation set of 323 cases with 90% specificity, and 96% sensitivity. Web
services were integrated in existing health information system platforms.
Conclusions: Specialized decision support can be offered as a complementary service to existing policies of
integrated care for chronic-disease management. The CDSS was able to issue recommendations that have a high
degree of accuracy to support COPD case-finding. Integration into healthcare providers’ work-flow can be achieved
seamlessly through the use of a modular design and service-oriented architecture that connect to existing health
information systems.
Introduction and background
An important problem in healthcare is the significant
gap between optimal evidence-based medical practice
and the care actually applied. A systematic review [1] of
adherence to chronic obstructive pulmonary disease
(COPD) guidelines by clinicians found that the assess-
ment of the disease and the therapy applied to patients
were suboptimal. This situation exists across all chronic-
disease care in general: in a multinational survey [2] of
chronically ill adults, 14-23% of cases reported at least
one medical error in the previous two years.
Clinical decision support systems (CDSSs) can be
defined as “software that is designed to be a direct aid
to clinical decision-making in which the characteristics
of an individual patient are matched to a computerized
clinical knowledge base (KB), and patient-specific assess-
ments or recommendations are then presented to the
clinician and/or the patient for a decision” [3]. CDSSs
have the potential to enhance healthcare and health, and
to help close the gap between optimal practice and
actual clinical care.* Correspondence: fvelickovski@bdigital.org
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The primary objective of the work reviewed in this
manuscript is to develop a set of decision-support ser-
vices so that health professional staff (primary care clini-
cians and allied health professionals) can obtain fast,
reliable and directly applicable advice when dealing with
citizens at risk and early-stage patients with COPD,
while minimising the impact in work-flows. Specifically,
to tackle under-diagnoses, a suite of case-finding ser-
vices has been developed in order to provide recom-
mendations for both informal (e.g. pharmacy) and
formal (e.g. primary care) clinical contexts at early
stages of disease development. The case-finding services
include a quality-control module to provide recommen-
dations, and expert-quality classifications for forced
spirometry tests performed by non-expert clinical provi-
ders (primary-care clinicians or allied healthcare provi-
ders, such as in a pharmacy) [4,5].
To support the management of disease heterogeneity,
decision support services for patient stratification into
treatment groups have been designed, relying on three
main aspects: firstly, enhancing applicability of well-
established rules recommended by the consensus report
for the diagnosis, management, and prevention of
COPD released by the Global Initiative for COPD
(GOLD guidelines) [6]; secondly, using the latest conso-
lidated knowledge on COPD management; and, thirdly,
incorporating the knowledge generated by the Synergy-
COPD European project, within which the research
described in this paper is framed.
Related work
Ten of the most critical challenges facing the design, devel-
opment, implementation and deployment of CDSS tech-
nology in healthcare were highlighted by a study Sittig et
al., 2008 [7]. From these ten “grand challenges”, reinforced
subsequently by Fox et al., 2010 [8], and relevant to the
context of this manuscript are (i) disseminate best practices
in CDS design, development, and implementation; (ii) cre-
ate an architecture for sharing executable CDS modules
and services; (iii) create internet-accessible clinical decision
support repositories. Furthermore, Kawamoto et al., 2005
[9], performed a systemic review of publications which
reported performance of CDSS systems that included
description of features. The objective was to determine a
correlation between successful CDSS and specific features.
They found successful CDSSs had the following three char-
acteristics: (i) Decision support integrated into the work-flow
; (ii) decision support delivered at the time and place of
decision making ; (iii) actionable recommendations.
Another systematic review of CDSSs was performed by
Roshanov et al., 2011 [10], with the objective to determine
if CDSSs improve the process of chronic care (in diagnosis,
treatment, and monitoring) and associated patient out-
comes. The authors identified 55 trials that measured and
reported the impact of the CDSS on the process of care,
and/or patient outcome. Out of the CDSSs that measured
the impact on the process of care, 52% demonstrated a sta-
tistically significant improvement, and out of the trials that
measured patient outcome 31% demonstrated benefits.
Specifically, for chronic respiratory diseases (asthma and
COPD), only one [11] of the nine reported a positive
impact in the process of care: a CDSS for the management
of drug therapy in severe asthma. From the five that mea-
sured impact on patient outcome, only two [12,13] reported
a benefit.
Closely related to our work, Hoeksema et al., 2011 [14]
performed a study to report the validity and accuracy of a
CDSS designed for the assessment and management of
asthma by leading medical institutions in the USA. The
system used a similar approach to the Synergy-COPD
CDSS by using rules extracted from the guidelines for
the diagnosis and management of asthma (EPR-3) [15].
The system assesses the severity of asthma, by applying
rules based on a set of inputs, from the patients symp-
toms, exacerbations, and spirometry (lung function) para-
meters. Furthermore it recommends the line of
treatment, based on the severity level and other factors.
The CDSS performed relatively accurately compared to
clinicians for the asthma assessment task (pulmonologists
agreed with the CDSS 67% of the time, and from the dis-
agreements an expert panel determined that the CDSS
was at error 68% of the time, making an overall accuracy
level of 78% for the CDSS). The result for the CDSS was
poor for the treatment recommendations (pulmonolo-
gists agreed with the CDSS 29% of the time, and from
the disagreements an expert panel determined that the
CDSS was at error 54% of the time, making an overall
accuracy level of 62% for the CDSS).
Methods
Architecture of the CDSS
The design of the architecture of a CDSS has an impor-
tant influence on its successful adoption [16]. Four prin-
ciple architectural models were considered (see also
Table 1):
(i) Standalone models: this architecture was used by
early CDSSs. Since it has no integration to an exter-
nal health information system (HIS) or electronic
health record (EHR), it requires the user to enter all
findings and clinical information, thus being time
consuming. The advantage of such systems is that
they are easily sharable and transferable to different
centres (i.e. just by copying the software across).
(ii) Integrated models: this architecture is tightly
coupled to the HIS or EHR. Such CDSSs may be
proactive in issuing alerts, and make less input
demands on users as the data are already available.
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The disadvantage of such a model is the difficulty to
be shared, as it is dependent on vendor specific HIS
or EHR;
(iii) Standard-based models: this architecture sepa-
rates the CDSS from the HIS and the EHR. Intero-
perability is achieved through a standardization of
the computerized representation of clinical knowl-
edge through the use of computer interpretable
guidelines (CIGs) [17-20].
(iv) Service-oriented models: this architecture (e.g.,
[21,22]) separates the CDSS from the HIS, but inte-
grates them using standardized, service based inter-
faces. The interface encodes the clinical data and
recommendations in a formal representation using
ontologies and vocabularies. Thus, standardization is
based on the data transferred between the HIS and
CDSS instead of the the guidelines and clinical rules
executed by the CDSS as in standard-based systems.
See [16] for an extensive review.
A service-oriented approach was selected for the
CDSS as it covered the most critical features as sum-
marized in Table 1. In this model the CDSS is interfaced
through a web service protocol, with clinical data being
exchanged through an interoperable format described
later in the section on clinical data representation. The
diagram in Figure 1 illustrates the architecture, showing
the main interfaces between the external user systems
and its internal components, which are described as
follows.
Controller
The CDSS Controller is responsible for coordinating all
communication between internal components and exter-
nal systems during the execution of a decision support
task. It manages user requests/responses that contain
clinical data from the patient communicated in the HL7
virtual medical record (vMR) format, the running of the
reasoning engine, the quality-control module, and the
reference-value module.
Reasoning engine and clinical knowledge base
CDSSs may be classified by the reasoning or inference
methods they use. These methods, along with demon-
strated implementations for COPD management, are
listed in Table 2. Approaches that explicitly model
knowledge are preferred in the clinical domain because
they facilitate the often-needed justification of the
recommendation. The work-flow driven approach, by
way of encapsulating clinical care protocols into compu-
ter interpretable guidelines, has been demonstrated by
J. Fox and his team successfully through the PROforma
language [23,24]. In Synergy-COPD, a rules-based rea-
soning paradigm was adopted for the CDSS. This
approach was to complement existing HISs (Linkcare
and Arezzo Pathways) that already implemented clinical
work-flows, thus focusing on the critical clinical decision
tasks in COPD management, modelled as production
rules.
Rule-based programming has its foundations in sym-
bolic production systems, and its basic approach is to
decompose a computation into a set of elementary
transformations, embodying, in the case of this research,
clinical tasks. Each elementary transformation attempts
to match its input against a set of templates, and, if
some of these match, a rule corresponding to one of the
templates is chosen, and the action associated with the
rule is executed. Most rule-based inference engines use
the Rete algorithm [25]. To represent rules, the CDSS
uses the open-source Java-based JBoss Drools [26],
which has an easier-to-interpret syntax than representa-
tions used by competing systems: CLIPS [27] and
Jess [28].
Figure 2 is an illustration of the reasoning paradigm
implemented by the CDSS. The rule-based engine oper-
ates on inserted facts about a patient that are trans-
mitted to the CDSS by the external HIS requiring
decision-support services. Facts may be particular clini-
cal findings or measurements or demographic informa-
tion about the patient (e.g. “forced vital capacity = 3.7
L"; “dyspnea’s MRC severity grade = 4"; “gender =
male”). Rules represent mathematical or logical knowl-
edge that infers (produces) new facts from currently
available facts. Clinical rules are a subclass of rules that
represent clinical and medical knowledge that infers
new facts or medical recommendations from currently
available medical facts. Clinical rules operate within a
modular context that allows, at any particular moment,
Table 1 Comparison of features in CDSS architectures.
Architectural model’s feature Stand-alone Integrated Standard-based Service-oriented
Service transferable across clinical centres Yes No Yes Yes
Manual data-entry to CDSS minimized No No Yes Yes
Connected to EHR or HIS No Yes Yes Yes
Vendor independent EHR or HIS N/A No Yes No
Standardized clinical knowledge representation No No Yes† Sometimes
Standardized clinical data representation No No Sometimes Yes
† despite an on-going effort for the last two decades, there is still not a widespread adoption of standard-based systems, nor a widespread CIG format
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firing only the specific set of rules associated with the
specific clinical task at hand (e.g. case-finding, diagnosis,
assessment).
In this paradigm, the clinician has to ultimately take the
final decision. The CDSS generates recommendations
based on the patient’s personal profile; each recommenda-
tion specifying a recommended course of action for the
clinician (e.g. “Diagnose patient with COPD.”) and the rea-
son why this is the case (e.g. “Symptoms consistent with
COPD according to GOLD guidelines’ criterion: FEV1/
FVC <0.7”). If a recommendation is accepted, it may either
automatically create new facts into the system augmenting
the patient’s medical profile (e.g. COPD added to the list
of diseases), or instruct the clinician to perform further
actions (e.g. “Take a spirometry measurement after apply-
ing a bronchodilator and report back the results.”).
Quality control module
The quality-control module implements an algorithm
for assessing the acceptability of an individual forced
spirometry manoeuvre. The automatic validation of the
spirometry measurements consists of identifying wrong/
flawed tests, or acceptable/valid tests. Hence an indica-
tion is provided regarding the quality of the measure-
ments performed, and feedback or indication is provided
regarding the reliability, or confidence level, of the man-
oeuvre or set of manoeuvres. This is used by an evaluator
to assess the quality of a full spirometry test comprising
more than one manoeuvre. No expert intervention is
necessary and support can be provided in a clinical set-
ting where the clinician or healthcare provider is not an
expert in spirometry tests.
Reference value module
The reference-value module invokes continuous pre-
diction equations and their lower limit of normal
(LLN) for clinical parameters - specifically, it uses
spirometric reference values specified by Hankinson et
al., 1999 [29] and Quanjer et al., 2012 [30] for case-
finding and diagnosis.
Figure 1 CDSS architecture depicting internal modules, external user HIS, and external supporting Synergy-COPD systems.
Table 2 Inference methods used in CDSS
Method Description Implementations
Work-flow driven
1
Logical flows contain statements that reference and manipulate clinical data, usually executed in a serial
manner, with control structures that direct the flow of decision making through the procedure.
[23,24]
Rules-based
reasoning 1
Medical knowledge is captured through a collection of IF-THEN expressions. Reasoning by forward chaining
(the most common one) links rules together until a conclusion is reached.
[50-52]
Probabilistic
reasoning 1,2
Bayesian networks and graphical representation that describes the causal relationships between diseases and
symptoms with conditional probabilities.
[53]
Machine learning
(ML) 2
Machine learning and statistical techniques, by learning or training, are used on existing, large datasets of
clinical data.
[54,55]
1Clinical knowledge explicitly modelled
2Clinical knowledge derived or learnt from data of past cases
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External supporting Synergy-COPD systems
The interfaces to Simulation Environment [31,32] and
Synergy-COPD Knowledge Base [33,34] (that host the pre-
dictive models [35-38] developed within the Synergy-
COPD project) have been developed for prognostic exten-
sions to the CDSS. Furthermore the Synergy-COPD
Knowledge Base is accessed for drug-drug interaction data.
Clinical data representation
The service-oriented architecture allows the CDSS to
deliver decision support capabilities to any external HIS
that is able to provide the input clinical data of the
patient and receive as output clinical recommendation
through a well specified Simple Object Access Protocol
(SOAP) interface defined in the web services description
language (WSDL). The underlying format that was
selected to contain the input clinical data was the HL7
virtual medical record (vMR) [39,40]. The vMR is a data
model for representing clinical data specifically opti-
mised for decision support tasks; it captures data about
the patient’s demographics, clinical history, and is also
designed to capture CDSS-generated recommended
actions such as suggested clinical interventions, thera-
pies, procedures, and assessments. Data in the vMR are
represented using user-defined vocabularies; to enhance
interoperability, standardised vocabularies with clear
semantics were used within the vMR messages to
encode clinical concepts. The vocabularies are shown in
Table 3, which includes an example concept and the
associated code.
Development
The CDSS was constructed using an iterative and incre-
mental development model adapted from [41]. Figure 3
shows the main development phases. After the initial
requirements specification, and design phase, the frame-
work containing the main CDSS components was devel-
oped. Three incremental cycles were completed to develop
the CDSS web services, and within each cycle the following
phases were executed:
(i) requirements adjustment - functionalities for sub-
sequent clinical task refined;
(ii) knowledge acquisition - clinical guidelines inter-
preted by respiratory specialists and defined as rules
or as algorithm;
(iii) knowledge engineering - translation of clinical
rules into Drools rules representation and classifica-
tion into specialized CDSS modules (quality control,
reference value);
(iv) validation and testing - input test cases and
expected output defined and tested against CDSS web
services;
(v) deployment - secure web service interface exposed
and integrated into an existing HIS platform.
Figure 2 Reasoning paradigm.
Table 3 Standardised vocabulary used in clinical data
exchange.
HL7 vMR item Vocabulary Example (Code)
Observation SNOMED-CT [56] forced vital capacity
(50834005)
Procedure SNOMED-CT spirometry test (127783003)
Problem
(Disease)
ICD-10 [57] COPD (J44)
Ethnicity Ethnicity - CDC [58] white (2106-3)
Language ISO 639 language code
[59]
English (en)
Figure 3 Adapted incremental software development model
for the CDSS.
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Results
Several decision-support web-services were deployed in
a secured environment online for preventive manage-
ment of COPD patients with performance benchmarked.
The web services were incorporated into two existing
HISs: all web services into the Linkcare platform [42]
and the spirometry quality control web service into Are-
zzo Pathways [43].
Decision support web services
Spirometry quality control
This service, through spirometry-test results consisting
of a set of raw signals from spirometry manoeuvres,
determines: quality grade (A, B, C, D or F) of the spiro-
metry test; best lung function parameters for the
volume that has been exhaled at the end of the first
second of forced expiration (FEV1), the vital capacity
from a maximally forced expiratory effort (FVC), the
highest forced expiratory flow (PEF), back extrapolated
volume (BEV), and their associated manoeuvres;
acceptability of each manoeuvre; ranking of each man-
oeuvre; for manoeuvres deemed to unacceptable, the
reasons for their rejection.
case-finding: Eligibility for spirometry test
Through an inclusion/exclusion criteria, represented as
Drools rules in the clinical knowledge-base, this service
generates advice on subjects at risk of COPD. Subjects
are selected for further investigation based on demo-
graphics, risk factors, and symptoms. The system pro-
duces patient-specific advice for: eligibility of the subject
for a further spirometry test; recommendations for smo-
kers based on their dependency.
Case finding: Preliminary evaluation
From the results of a pre-bronchodilation spirometry of
an eligible subject, this service determines: requirement
to refer the subject to primary care for further tests;
preliminary evaluation of lung function; cessation advice
for smokers based on their dependency.
Diagnosis: Primary care evaluation
From a patient’s full exam consisting of pre-bronchodi-
lation and post-bronchodilation spirometry, this service
determines probable COPD cases, evaluates lung func-
tion, and issues cessation advice for smokers based on
their dependency.
Assessment: Patient stratification
From a patient’s post-bronchodilation spirometry result
and index scores from standard questionnaires (COPD
assessment test [44], modified Medical Research Council
dyspnea scale [45]) the patient is stratified into the
GOLD 2011 [6] categories: group A - low exacerbation
risk, less symptoms; group B - low exacerbation risk,
more symptoms; group C - high exacerbation risk, less
symptoms; group D - high exacerbation risk, more
symptoms. Each stratification group has an associated
recommended set of pharmacological and non-pharma-
cological therapies.
Evaluation of the CDSS as a diagnosis service
Validation dataset
The performance of the CDSS diagnosis service was
compared with an anonymised database of patients
from Primary Care centres participating in forced-
spirometry training in a web-based remote support
program to enhance quality of forced spirometry done
by non-expert professional in the Basque Country
region of Spain. Forced-spirometry testing was done
using a Sibel 120 SIBELMED spirometer. The spirome-
try quality and diagnosis evaluation was done by one
respiratory specialist. Inclusion criteria to form the
validation data set were:
(i) age of the patient greater than or equal to 40;
(ii) forced spirometry taken and recorded as an elec-
tronic record before and after the application of
bronchodilators;
(iii) respiratory specialist used option menu to select
the appropriate diagnosis (rather than entered
through the free text field).
After applying the inclusion criteria, the validation set
was formed containing 323 cases. The use of the dataset
for validation purposes was approved by the Ethical Com-
mittee of the Hospital Clinic í Provincial de Barcelona.
Benchmarking the diagonisis service
The clinical data for each case in the validation set was fed
into the CDSS diagnosis service, the result was compared
against the respiratory specialist classification of the case.
The mapping in Table 4 was used to compare the specialist
classification to the CDSS for the purposes of validation.
Sensitivity and specificity of the CDSS were calculated
for cases in the validation set classified as Likely COPD
or Unlikely COPD.
sensitivity =
TP
TP + FN
(1)
specificity =
TN
TP + FP
(2)
Table 4 Mapping from respiratory specialist classification
to CDSS diagnosis classification.
Specialist class CDSS class
Normal, no obstruction pattern Unlikely COPD
Mild, obstruction pattern Likely COPD
Moderate obstruction pattern Likely COPD
Severe obstruction pattern Likely COPD
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wherein TP (true positive) corresponds to cases classi-
fied as Likely COPD by both CDSS and the specialist; TN
(true negative) corresponds to cases classified as Unlikely
COPD by the CDSS and the by the specialist; FP (false
positive) indicates cases classified as Likely COPD by the
CDSS, but classified as class Unlikely COPD by the spe-
cialist; and, FN (false negative) corresponds to cases clas-
sified as Unlikely COPD by the CDSS, but as Likely
COPD by the specialist. The CDSS produced 101 diagno-
sis recommendations as likely COPD, and 222 recom-
mendations as unlikely COPD. 297 cases correctly
matched the assessment of the specialists (92%). Sensitiv-
ity and specificity calculations were calculated to be 90%
and 96%, respectively. Table 5 shows the details of these
results as a confusion matrix.
Integration
The CDSS operates by receiving and sending standardized
messages, and relies on an existing HIS to present its
recommendations to the healthcare professional on screen
or via the issuance of a report. Two such HISs have suc-
cessfully implemented the CDSS web services. The CDSS
response time for all decision support services was accep-
table (within seconds) to the clinical task at hand, and
thus allowed a seamless integration into the existing HIS.
Linkcare
Linkcare is an integrated-care open platform allowing
healthcare professionals (specialists, general practi-
tioners, case managers, nurses, etc.) to share clinical
knowledge around a patient centric model. A Linkcare
mobility module allows posting activities to be per-
formed by patients, using their smart-phone, tablet or a
web portal. Such activities include follow-up question-
naires and medical measurements, such as measure-
ments by pulse-oximeters, glucometers and spirometers,
and measurements of blood pressure. Healthcare profes-
sionals can exchange care protocols and clinical data
around Integrated Practice Units or specific Clinical
Research teams. Integrating the CDSS web services with
the Linkcare platform allows healthcare professionals to
be assisted in making clinical decision relating to case-
finding, diagnosis, and stratification of COPD patient.
Arezzo Pathways
Arezzo Pathways combines best practice clinical guidelines
with individual patient data to dynamically generate care
pathways and provide decision recommendations specific
to each patient at the point of care. This assists clinicians
in managing patients with long-term conditions and in
making timely and appropriate referrals. The CDSS web
service offering spirometry quality-control and quality-
assurance has been integrated into Arezzo Pathways.
Communication protocol
Figure 4 shows the use of the CDSS through a primary
care scenario and the exchange of messages between
Linkcare and the CDSS web services, with the objective
for a clinician to confirm COPD in a patient. The clini-
cian uses the Linkcare platform to enter the details of
the patient in the system, or retrieve them from the
EHR. The patient has already been assessed as being at
risk of COPD, and the primary care clinician needs to
confirm the COPD. For this, the primary care clinician
needs to perform a full spirometry exam, i.e. two tests:
one before the application of bronchodilators, and one
after. To ensure the measurement taken with the spi-
rometer satisfies criteria for an acceptable and reliable
test, the full sampled signal, along with the lung func-
tion parameters are sent as two request messages, one
for each test (pre and post-bronchodilation), to the
Spirometry Quality Control web service. Linkcare uses
the Diagnosis - Primary Care Evaluation web service to
support the clinician in the decision of the diagnosis of
the patient. The Linkcare platform sends the CDSS a
request message with details of the lung function para-
meters obtained during the spirometry measurement.
The CDSS replies with a response containing the eva-
luation to confirm the diagnosis and a recommendation
to schedule an appointment for further evaluation and
stratification.
Discussion and conclusion
A large epidemiological report on the prevalence and
burden of respiratory disorders carried out in the gen-
eral population of Catalonia [46] stresses two important
facts in relation to COPD: (i) There is high prevalence
in the population greater than 65 years of age (36% in
men and 22% in women); (ii) there is a significant level
of under-diagnoses (76%). Moreover, in the UK, over
25% of people with a diagnostic label of COPD have
been wrongly diagnosed, usually because of poorly-per-
formed spirometry [47]. This research addresses the
above issues by targeting the identification of occult
COPD cases aiming at a better delineation of the natural
history of the disease. The CDSS services for detection
and diagnosis provide this capability, and an initial vali-
dation of the diagnostic potential of the CDSS shows
promising results (overall accuracy of 92%) in the ability
to provide high quality recommendation service for the
diagnosis of COPD.
Table 5 Confusion matrix of diagnosis
Specialist diagnosis
Likely COPD Unlikely COPD
CDSS Diagnosis Likely COPD 78 23
Unlikely COPD 3 219
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The Global Initiative for Chronic Obstructive Lung
Disease (GOLD) consensus report released initially in
2011 Global Strategy for the Diagnosis, Management,
and Prevention of COPD [6] recommended a major revi-
sion in the management strategy for COPD. An updated
report released in January 2014 maintains the same
treatment paradigm. Assessment of COPD is based on
the patient’s level of symptoms, future risk of exacerba-
tions, the severity of the spirometric abnormality, and
the identification of co-morbidities. This assessment has
a limited practical applicability because of its complex-
ity. To facilitate the adoption of the new GOLD classifi-
cation, it has been incorporated as clinical rules into the
clinical knowledge-base, and deployed as a CDSS ser-
vice. And because an increasing number of reports indi-
cate that the new GOLD classification is not providing
added value in terms of clinical impact [48], future
activities will be devoted to the development of richer
stratification schemes that enrich the assessment cap-
abilities of the CDSS using existing knowledge that is
not incorporated in current schemes (i.e. information
about general health status, disease severity, activity
level, co-morbidities and use of healthcare resources),
and by including new knowledge acquired in the
Synergy-COPD European research project.
Another revision in the GOLD report was spirometry
changed from being a supportive diagnostic tool, to be a
requirement for the diagnosis of COPD. This has pro-
duced a strong need to support spirometry testing carried
out by non-specialized professionals in primary care and
allied health providers. This need is addressed through the
spirometry quality control CDSS service capable of near
expert level feedback on forced-spirometry manoeuvres.
An article focusing on the module and performance of the
quality control service is to appear in the Journal of Medi-
cal Internet Research [49].
Finally the research we present confronts the chal-
lenges and applies the characteristics that were originally
highlighted in the related work. Firstly, it demonstrates
through the modular design and service-oriented archi-
tecture of the CDSS framework, the capability of making
available internet accessible decision-support modules
and services shareable by multiple external HIS plat-
forms. Furthermore the CDSS is able to be directly
embedded into the user’s work-flow by integration into
existing HIS platforms with recommendations generated
at the time and place of decision making.
Limitations
We acknowledge three principle limitations of the study.
Firstly, only data from one respiratory expert was used as
ground truth for comparison to the CDSS recommenda-
tion in the evaluation. Ideally further independent valida-
tion, involving a panel of experts would be more robust in
evaluating CDSS performance. Secondly, although our
design allows for multiple HIS distributed across the
world to use the single CDSS specialised in COPD, we
acknowledge guidelines in diagnosis, assessment, and
treatment will differ across national borders to suit specific
population. The CDSS’s modular design allows for
instances of the CDSS to be deployed that cater for the
specific medical policy or protocol, only by modification of
the rules. Thirdly, although a CDSS may achieve a high
degree of accuracy and performance, the impact of when
Figure 4 System interaction during confirmation of a COPD diagnosis in a primary care setting.
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it is deployed in an actual healthcare setting needs to be
assessed separately before plans for large scale deployment
are developed. As part of this deployment process, the cur-
rent version of the CDSS is going through a qualitative
evaluation using a focus group approach that includes: pri-
mary care physicians, nurses, pharmacists and respiratory
specialists. A protocol to assess the clinical impact of the
use of the CDSS is to be initiated.
Conclusion
Specialized decision support can be offered as a comple-
mentary service to existing policies of integrated care for
chronic-disease management. The current research has
generated a CDSS capable of addressing important issues
facing COPD management in case-finding, diagnosis and
stratification. The CDSS is able to issue recommendations
that have a high degree of accuracy to support COPD
case-finding. Moreover, integration into healthcare provi-
ders’ work-flow has been demonstrated through the use
of a modular design and service-oriented architecture
that connect to existing health information systems
already in use.
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